Uncategorized Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects Post Content
Uncategorized JMP Sees Big Gains in Rapport Therapeutics, Inc. (RAPP) After Focal Epilepsy Study Success Post Content
Uncategorized JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval Post Content
Uncategorized Clear Street Initiates Buy on Dianthus Therapeutics, Inc. (DNTH) With $100 Price Target Post Content
Uncategorized Dragonfly Energy Holdings Corp. (DFLI) Upgraded to Hold After Ember RV Deal Post Content